Discovery may help provide clues for fighting and treating HPV
Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells. Their findings, published online today in the journal Cell, may eventually help to broaden the scope of defenses against HPV and provide valuable clues for delivering drugs into cells. HPV is a family of killers. Although there are effective vaccines against these viruses, they still cause about 5% of cancer deaths worldwide, including more than 250,000 women who die of cervical cancer each year.
New Simple Proteins Play Active Role in Cellular Function
Yale scientists have developed simple new proteins almost devoid of chemical diversity that still play a surprisingly active and specific role in cellular function, causing cells to act like cancer cells, they report Aug. 10 in the Proceedings of the National Academy of Sciences.
Two Yale Stem Cell Center members, Daniel DiMaio and Laura Niklason, have been elected to the Connecticut Academy of Science and Engineering.
Two Yale Stem Cell Center members, Daniel DiMaio and Laura Niklason, have been elected to the Connecticut Academy of Science and Engineering.Source: Connecticut Academy of Science and Engineering
New proteins inhibit HIV infection in cell cultures
Yale Cancer Center scientists have developed a new class of proteins that inhibit HIV infection in cell cultures and may open the way to new strategies for treating and preventing infection by the virus that causes AIDS. The findings appear in the online edition of the Journal of Virology.
The war on AIDS: Newly Developed Proteins Inhibit HIV Infection
Yale Cancer Center scientists have developed a new class of proteins that inhibit HIV infection and may open the way to new strategies for treating and preventing infection by the virus that causes AIDS. The findings appear in the July 18 online edition of the Journal of Virology.
Daniel C. DiMaio, M.D., Named Scientific Director of Yale Cancer Center
Yale Cancer Center Director Dr. Richard L. Edelson announced the appointment of Daniel DiMaio, M.D., PhD, to Scientific Director of the Center. In this role, DiMaio will have broad oversight of all basic science research within Yale Cancer Center (YCC).Source: Yale Office of Public Affairs and Communications
$7.5 Million Grant to Yale Researchers for Role of Viruses in Cancer
The National Cancer Institute recently awarded a five-year, $7.5 million program project grant to investigators at the Yale School of Medicine to continue studies on the role of viruses and mutant cellular proteins in tumorigenic transformation of cells.
Development and Validation of the Psychiatric Inpatient Experience (PIX) Survey: A Novel Measure of Patient Experience Quality Improvement
David Klemanski, PsyD, MPH, assistant professor of psychiatry, recently published a paper about a new survey he created alongside colleagues Todd Barnes and Cynthia Bautista to measure patient experience for inpatient psychiatry. The measure itself is part of a larger project of patient experience measures within Psychiatry and Behavioral Health.Source: Journal of Patient Experience
Garakani Named Outstanding Young Alumnus by SUNY Upstate Medical University
Amir Garakani, MD, DFAPA, assistant professor of clinical psychiatry and chair of psychiatry and behavioral health at Greenwich Hospital, has been named Outstanding Young Alumnus by SUNY Upstate Medical University in Syracuse, NY.
Sen appointed Medical Director for Cardiac Transplantation and Mechanical Circulatory Support Program
Yale Cardiovascular Medicine and the Yale New Haven Health Heart and Vascular Center are pleased to announce the formal appointment of Sounok Sen, MD, as the new Medical Director of the Cardiac Transplantation and Mechanical Circulatory Support Program.
Why a Placebo Can Work — Even When You Know It's Fake
John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; and Chair of the Yale Department of Psychiatry, spoke to National Geographic for a story about the effectiveness of placebo pills.Source: National Geographic
Psychedelic Medicine: Creating an Introductory Course for Mental Health Professionals and Trainees
William Prueitt, MD, third-year resident, and Jordan Sloshower, MD, MSc, clinical instructor, are co-authors of a paper in Academic Psychiatry that describes the Yale Department of Psychiatry's elective course on psychedelic medicine.Source: Academic Psychiatry
New Haven Community Gathers to Celebrate Yale Psychiatry's Kathy Carroll, Plan Playground in Newhallville
The Kathy Carroll Community Playground, currently planned in the Newhallville neighborhood of New Haven, will bring a safe place to play for children living at and nearby Christian Community Action (CCA): deep purple tunnels and slides, climbing structures and even a swing set. It’s a project the late Kathleen “Kathy” Carroll, PhD, who supported CCA for decades, would be proud of.